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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of evidence. 
Sarah Gilbert: carving a path towards a COVID-19 vaccine 
Lane R | The Lancet | 18 April 2020 | Perspectives 
https://doi.org/10.1016/S0140-6736(20)30796-0 
Prof Gilbert and her team was able to move quickly as they “had recently started thinking about an 
appropriate response to Diseases X; how could we mobilise and focus our resources to go more 
quickly than we had ever gone before. And then Disease X arrived”. Previous work on recombinant 
viral vector vaccines at the Jenner Institute in Oxford, which has progressed work on many 
vaccines, including those for influenza and Zika virus, and early stage trials for a MERS vaccine 
provided a helpful template for the work on a COVID-19 vaccine. Once the genome sequence of 
SARS-CoV-2 became available in mid-January, Prof Gilbert and her team began work on 10 
January on designing a vaccine using recombinant DNA techniques to create a SARS-CoV-2 
antigen within a primate adenovirus vector. Since awarded a £2.2 million grant from the UK’s NIHR 
and the UKRI in March a clinical trial in healthy humans is underway with hopes to have vaccinated 
500 volunteers by mid-May; followed by an extension of the maximum age of trial volunteers from 
55 to 70 years, later moving on to the over-70 age group. Phase 3 expansion is expected to involve 
5000 volunteers with an efficacy result and the ability to manufacture large amounts of the vaccine 
by the autumn of 2020. These are best-case timeframes, highly ambitious and could change. How 
grants have been awarded to different strategic aspects of the project is enabling important parallel 
work. For example, Sandy Douglas has received funding for a vaccine manufacturing scaling-up 
project at the same time as vaccine development trials. 
As outcomes are uncertain, pick no-regret policies 
Dercon, S | Center for Global Development | 17 April 2020 | Blog 
https://www.cgdev.org/blog/as-outcomes-are-uncertain-pick-no-regret-policies 
“Following the science” is good advice but when the evidence base is thin, such uncertainty in 
terms of health, social and economic outcomes makes policymaking hard and it helps to focus on 
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decisions that that no one will regret later irrespective of what happens next e.g. whether the crisis 
is short or long, the recession deep or shallow. It is clear that exit from this crisis will involve large-
scale deployment of a vaccine. No one will regret funding the Coalition for Epidemic Preparedness 
Innovations (CEPI) researching and developing a vaccine and organisations like GAVI getting the 
resources to help countries to build up the capacity to deliver vaccines. It is worth spending public 
money now to derisk the required large-scale manufacturing, even if that means destroying 
vaccines that prove not to be effective, as this is still good value for money and boosts the chances 
to have the required numbers of doses of a working vaccine earlier than usual. No one will regret 
investing in the reach and quality of community healthcare and the protection of health workers. 
“Community healthcare workers will be key to making sure that the collateral health damage from 
the measures to stop the spread of COVID-19 are kept to an absolute minimum”. 
Investing in data is key during such huge uncertainty – required for better policymaking. Decision-
making will have to be highly adaptive as data becomes available with politicians needing to be 
authoritive communicators, explaining in a clear narrative why decisions are taken and may need 
to be reversed. 
No-regret policies for the COVID-19 crisis in developing countries 
Dercon, S | Center for Global Development | 17 April 2020 | CDG Notes 
https://www.cgdev.org/publication/no-regret-policies-covid-19-crisis-developing-countries 
In this short note, Dercon discusses no-regret policies for developing countries and international 
agencies in three areas: health, vaccine development, and economic rescue. This note identifies 
nine interrelated actions in three areas where developing countries could be proactive: in public 
health, specifically linking to community health care; in vaccine development, production and 
distribution (and other medical supplies essential for the exit and recovery); and in preparing now 
for a better recovery for economies, firms and families. Resources spent here will not be wasted 
or regretted in any scenario. Three lessons for low-regret decision making under extreme 
uncertainty are (1) collect data now to reduce uncertainty; (2) change and adapt decisions if the 
data require it; and (3) focus on trust and communication. 
COVID-19: Global ceasefire would be a gamechanger for 250 million children living in 
conflict-affected areas 
UNICEF Executive Director Henrietta Fore | 17 April 2020 | Statement 
https://www.unicef.org/press-releases/covid-19-global-ceasefire-would-be-gamechanger-250-
million-children-living-conflict 
Today there are 250 million children around the world living in areas under conflict that need 
warring parties to respond to the call a month ago from the UN Secretary General for a global 
ceasefire to confront the COVID-19 pandemic. Yet violent conflict continues in parts of 
Afghanistan, Burkina Faso, Libya, Mali, Syria, Ukraine and Yemen, among others. There has been 
some response with parties to conflicts in 11 countries committing to a cessation of hostilities 
during the pandemic – but ceasefire agreements should be made that last beyond the end of the 
pandemic and lay groundwork for a durable and lasting peace. This statement lists immediate 
actions beyond a ceasefire that need to be done to make a meaningful difference to children. 
Authorities and groups controlling territory should facilitate open access for humanitarian 
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personnel to enable reach to children and their families with essential services and the repair and 
rebuild of key infrastructure, so populations are better protected from the spread of COVID-19. 
Armed forces and groups must not impede delivery of relief supplies or prevent those in need 
accessing services. Parties to conflicts should release any children being held in detention in 
relation to armed conflict or national security and release children from within their ranks.  
Strengthening accountability of the global health metrics enterprise 
Shiffman, J & Shawa YR | The Lancet | 16 April 2020 | Viewpoint 
https://doi.org/10.1016/S0140-6736(20)30416-5 
Authors contend that there are strong reasons to accept global health metrics as a public good. 
For example, credible epidemiological data are vital for addressing COVID-19. However, many 
valid concerns of critics are overlooked. In this Viewpoint these criticisms are discussed, and 
authors offer ideas for strengthening accountability of the global health metrics enterprise.   
Habitat fragmentation, livelihood behaviors, and contact between people and nonhuman 
primates in Africa 
Bloomfield, L et al | Landscape Ecology | 1 April 2020 | Article 
https://link.springer.com/article/10.1007/s10980-020-00995-w 
This study has suggested that deforestation of forests into fragmented patches could lead to a rise 
in the occurrence of zoonotic or animal-to-human diseases like COVID-19. Analysis of geographic 
factors and behavioural traits revealed how the loss of tropical forests in western Uganda led to 
increased physical interactions between humans and wild nonhuman primates and a greater risk 
of exposure to the viruses they carry. Large, healthy diverse habitats with fewer borders on human 
populations would help and economic development so that families would not have to take over 
forest land for subsistence farming. 
Tracking the World Bank’s response to COVID-19 
Duggan, J & Sandefur, J | Center for Global Development | 14 April 2020 | Blog 
https://www.cgdev.org/blog/tracking-world-banks-response-covid-19 
Millions of people who will be hit hardest by the global economic downturn due to COVID-19 live 
in countries with little or no social safety net, and limited capacity for a fiscal response. The World 
Bank announced on 2 April that $160 billion in funds will be made available for strengthening 
developing country responses to COVID-19 over the next 15 months. This blog goes on to discuss 
where will these funds go and under what terms; how quickly the World Bank will respond; and is 
$160 billion enough. To track the World Bank’s response, authors have built an interactive tool to 
display how much each country has received to date and what is waiting for approval. 
COVID-19 in humanitarian settings and lessons learned from past epidemics 
San Lau et al| Nature | 8 April 2020 | Blog 
https://www.nature.com/articles/s41591-020-0851-2 
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Noting that displaced populations may suffer more from covid-19 due to overcrowding and lack of 
access to healthcare and hygiene facilities, as well as being affected by restrictions on movement, 
the blog shows lessons from past outbreaks. These lessons include maintaining essential health 
services (e.g. ' Possible approaches include alternative treatment-delivery methods, supply-chain 
management and the provision of extended medication supplies for conditions including HIV, 
tuberculosis and non-communicable diseases, as well as modern contraceptive methods' and 
helping health workers continue to work); ensuring access to infection control measures for 
displaced populations; and community engagement. 
REINFORCE, REINFORCE, REINFORCE: Localization in the COVID-19 Global 
Humanitarian Response 
International Council of Voluntary Agencies | 30 March 2020 | Report  
https://www.icvanetwork.org/system/files/versions/ICVA_Localization_COVID19.pdf 
Noting that humanitarian responses will have to become more localised due to Covid-19 travel 
restrictions, the report seeks to highlight best practice in localisation. It is structured around seven 
areas: Partnerships, Leadership, Coordination and Complementarity, Participation, Policy 
Influence and Advocacy, Capacity, and Funding. 
U-Report 
http://ureport.mw/opinion/4090/ 
U-Report is a free mobile-based opinion polling service for young people giving youth an 
opportunity to share their views. Here are the latest polls on COVID-19 which can be selected by 
country. 
Online learning and events 
Emerging respiratory viruses, including COVID-19: methods for detection, prevention, 
response and control 
WHO | Free | 3 hours duration  
https://openwho.org/courses/introduction-to-ncov 
A general introduction to enable you to describe the fundamental principles of emerging 
respiratory viruses, including novel coronaviruses, and how to effectively respond to an outbreak. 
Intended for public health professionals, incident managers and personnel working for the UN, 
international organisations and NGOs. 
Responding to COVID-19: Real-time training for the coronavirus disease outbreak 
WHO | Available now | multiple self-paced courses 
https://openwho.org/channels/covid-19 
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Note that courses are available in English and other languages including French, Portuguese 
and Spanish. 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 25 May 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
Unfacilitated access to this course remains. An updated version of this course will though be run 
from 25 May 2020. On this course you will learn what is known about the outbreak of COVID-19 
(week 1); what the practical implications for responding to COVID-19 are (week 2); and what we 
need to find out about COVID-19 (week 3). 
COVID-19 Diagnostics and Testing 
FIND, LSHTM & ASLM | FutureLearn course | Starts 20 April 2020 | 3 weeks | 3 hours weekly 
study | Free 
https://www.futurelearn.com/courses/covid-19-diagnostics-and-testing 
This course is designed for professionals involved in the testing and diagnosis of COVID-19, with 
a focus on low- and middle-income settings. You will learn the latest recommendations on COVID-
19 testing, get upt0date information on the performance of tests and how best to deploy them. 
COVID-19 Critical Care: Understanding and Application 
University of Edinburgh & Royal College of Physicians of Edinburgh  | FutureLearn course | 
Starts 6 April 2020 | 5 weeks | 1 hour weekly study | Free 
https://www.futurelearn.com/courses/covid-19-critical-care-education-resource 
Designed for frontline clinical staff to learn the principles and practice of critical care to treat and 
care for critically ill patients during the COVID-19 pandemic. You will learn (1) how to apply the 
current and evolving principles of PPE in the care of COVID-19; (2) apply evidence-based 
principles of advanced organ support and monitoring to the COVID-19 critically ill patients; (3) 
apply evidence-based daily practices to care of the critically ill patient; and (4) develop a range of 
specialised self-caring practices. 
Note that this resource has been created in response to the COVID-19 emergency and does not 
correspond to the classic structure of a FutureLearn course. You do not have to follow the week 
by week approach and can select the materials most relevant to your work. 
Tracking Dashboards 
Global WHO sitreps 
 Johns Hopkins University  
 WEF 
 Vaccine Centre LSHTM 
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 Our World in Data 
 Global 5050 
 Humanitarian Data Exchange 
 Information is Beautiful 
 The Commons Project 
Regional  WHO Africa  
 African Arguments 
 European CDC 
Country Ghana 
 Indonesia 
 Sierra Leone 
 Singapore 
 UK 
 US 
Guidelines 
Global WHO 
 IASC 
Regional Africa CDC 
Country Nigeria CDC 
 UK Government 
 UK ONS 
 NICE UK 
 US CDC 
Resource Hubs 
Multilaterals WHO 
 WHO risk communication 
 WHO Q&A 
 
WHO Global research 
COVID-19 Solidarity Response Fund 
 UN 
 UN Women 
 
UNOCHA 
UNHCR 
 UNICEF 
 UNESCO 
 UN WFP 
 World Bank 
Regional & Country 
 
 
Africa CDC 
African Union 
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Academic journals The Lancet 
 NEJM 
 Elsevier 
 BMJ 
 Cell 
 PLoS 
 Cochrane reviews 
Global Health Institutes LSTM 
 LSHTM 
 Johns Hopkins University 
 ICL MRC Centre for Global Infectious Disease Analysis  
 ODI 
 Norwegian Institute of Public Health 
Ethics Rings HSG Resyst Reach Wellcome  
Clinical trials US NIH registered clinical trials  
Funding bodies UKRI 
 Wellcome 
Demographics WorldPop 
Global Impact Surveys Premise COVID-19 Global Impact Study 
 GeoPoll: SSA 
TB Stop TB Partnership 
Disability IDA 
 Disability and inclusion 
 Coregroup IDDC  
SDGs Global Partnership for Sustainable Development Data  
Humanitarian Reliefweb 
 Humanitarian OpenStreetMap Team  
 SSHAP 
Narratives David Nabarro, WHO DG Special Envoy on COVID-19 
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About this report 
This daily COVID-19 health evidence summary is based on 3 hours of desk-based research. K4D services are 
provided by a consortium of leading organisations working in international development, led by the Institute of 
Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield Centre for 
International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of Birmingham 
International Development Department (IDD) and the University of Manchester Humanitarian and Conflict 
Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for International 
Development (DFID) and its partners in support of pro-poor programmes. It is licensed for non-
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